Pharmacotherapy of fungal eye infections

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 11, 2001, Pages 1849-1857

  Manzouri, B ^a   Vafidis, G C ^a   Wyse, R K H ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Antifungal drugs; Fungal endophthalmitis; Fungal keratitis

Indexed keywords

ALLYLAMINE; AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; CHLORHEXIDINE; CLOTRIMAZOLE; CORTICOSTEROID; ECONAZOLE; FLUCONAZOLE; FLUCYTOSINE; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NATAMYCIN; NYSTATIN; POLYENE; PYRROLE; TERBINAFINE; TRIAZOLE;

ALLERGY; APLASTIC ANEMIA; CONTACT LENS; CONTROLLED STUDY; CORNEA EPITHELIUM; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG USE; ENDOPHTHALMITIS; EYE INFECTION; EYE INJURY; FEVER; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS; HUMAN; KERATITIS; KERATOMYCOSIS; KIDNEY DISEASE; LEUKOPENIA; LIVER NECROSIS; LONG TERM CARE; MALAISE; MOLECULAR WEIGHT; MYCOSIS; PHLEBITIS; PRESERVATION; REVIEW; RISK FACTOR; SMEAR; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; UREMIA; VISION; WEIGHT REDUCTION;

ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; EYE INFECTIONS, FUNGAL; HUMANS; STEROIDS;

EID: 0035175481     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.11.1849     Document Type: Review

References (42)

1. Anterior ocular infections: An overview of pathophysiology and treatment
2. Fungal keratitis in a daily disposable soft contact lens wearer
3. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis
4. Fluconazole in the management of fungal ocular infections
5. Keratitis
6. New antifungal drugs in ophthalmology
7. Fungal keratitis
8. Principles in the management of oculomycosis
9. The microbiology of the eye
10. Therapy for bacterial and fungal infections
11. Topical antimycotics in ophthalmology
12. Mycosis of the eye and its adenexa
13. Advances in the management of keratomycosis and Acanthamoeba Keratitis
14. Treatment of keratomycosis with amphotericin B 0.15%
15. Corneal penetration of topical amphotericin B and natamycin
16. Exogenous fungal endophthalmitis
17. Pseudallescheria boydii keratitis
18. Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method
19. In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens
20. Treatment of postkeratitis Fusarium endophthalmitis with amphotericin B lipid complex
21. Antimicrobial agents
22. Fluconazole and itraconazole: Current status and prospects for antifungal therapy
23. Penetration of topical fluconazole into human aqueous humor
24. Intravenous itraconazole
25. Strategies in the treatment of systemic fungal infections
26. Mycotic keratitis: Suspectibility to antiseptic agents
27. Alternative modalities of administering amphotericin B: Current issues
28. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease
29. The role of steroids in the management of Acanthamoeba keratitis, fungal keratitis, and epidemic keratoconjunctivitis
30. Keratomycosis: A preventable disease
31. Efficacy of antifungal agents in the cornea: Influence of corticosteroids
32. Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis
33. Use of PCR in endophthalmitis
34. Recurrent fungal keratitis and endophthalmitis
35. Endophthalmitis
36. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh
37. Disinfectants and antiseptics. A. By chemical type: Chlorhexidine
38. The cost of treating systemic fungal infections
39. Prognosis of endogenous fungal endophthalmitis and utility of Ishibashi's classification
40. Proposed classification of stages of endogenous fungal endophthalmitis